These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24842908)
1. Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011. Schillberg E; Isaac M; Deng X; Peirano G; Wylie JL; Van Caeseele P; Pillai DR; Sinnock H; Mahmud SM Clin Infect Dis; 2014 Sep; 59(5):651-7. PubMed ID: 24842908 [TBL] [Abstract][Full Text] [Related]
2. Clonal spread of serotype 12F ST4846 Ohkusu M; Takeuchi N; Ishiwada N; Ohkusu K J Med Microbiol; 2019 Sep; 68(9):1383-1390. PubMed ID: 31347997 [No Abstract] [Full Text] [Related]
3. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A; Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556 [TBL] [Abstract][Full Text] [Related]
4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268 [TBL] [Abstract][Full Text] [Related]
5. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C; Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302 [TBL] [Abstract][Full Text] [Related]
6. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B; J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772 [TBL] [Abstract][Full Text] [Related]
7. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage. Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska. Zulz T; Wenger JD; Rudolph K; Robinson DA; Rakov AV; Bruden D; Singleton RJ; Bruce MG; Hennessy TW J Clin Microbiol; 2013 May; 51(5):1402-7. PubMed ID: 23408692 [TBL] [Abstract][Full Text] [Related]
9. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017. Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246 [TBL] [Abstract][Full Text] [Related]
10. Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel. Rokney A; Ben-Shimol S; Korenman Z; Porat N; Gorodnitzky Z; Givon-Lavi N; Ron M; Agmon V; Dagan R; Valinsky L Emerg Infect Dis; 2018 Mar; 24(3):453-461. PubMed ID: 29460732 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan. Shimbashi R; Chang B; Tanabe Y; Takeda H; Watanabe H; Kubota T; Kasahara K; Oshima K; Nishi J; Maruyama T; Kuronuma K; Fujita J; Ikuse T; Kinjo Y; Suzuki M; Kerdsin A; Shimada T; Fukusumi M; Tanaka-Taya K; Matsui T; Sunagawa T; Ohnishi M; Oishi K; PLoS One; 2019; 14(2):e0212418. PubMed ID: 30789928 [TBL] [Abstract][Full Text] [Related]
12. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016. Demczuk WHB; Martin I; Desai S; Griffith A; Caron-Poulin L; Lefebvre B; McGeer A; Tyrrell GJ; Zhanel GG; Gubbay J; Hoang L; Levett PN; Van Caeseele P; Raafat Gad R; Haldane D; Zahariadis G; German G; Daley Bernier J; Strudwick L; Mulvey MR Vaccine; 2018 Jul; 36(31):4701-4707. PubMed ID: 29937245 [TBL] [Abstract][Full Text] [Related]
13. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults. Nakanishi N; Yonezawa T; Tanaka S; Shirouzu Y; Naito Y; Ozaki A; Hama N; Ijichi A; Iwamoto T; Nomoto R J Infect Public Health; 2019; 12(6):867-872. PubMed ID: 31204116 [TBL] [Abstract][Full Text] [Related]
15. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165 [TBL] [Abstract][Full Text] [Related]
16. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ; Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450 [TBL] [Abstract][Full Text] [Related]
17. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
18. Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England. Foster D; Knox K; Walker AS; Griffiths DT; Moore H; Haworth E; Peto T; Brueggemann AB; Crook DW; On Behalf Of The Oxford Invasive Pneumococcal Surveillance Group J Med Microbiol; 2008 Apr; 57(Pt 4):480-487. PubMed ID: 18349369 [TBL] [Abstract][Full Text] [Related]
19. An outbreak of serotype-1 sequence type 306 invasive pneumococcal disease in an Australian Indigenous population. Cook HM; Giele CM; Jayasinghe SH; Wakefield A; Krause VL; Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988336 [TBL] [Abstract][Full Text] [Related]
20. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]